Isracann Biosciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISCNF research report →
About the company
Isracann Biosciences Inc. , operating with its subsidiary companies, focuses on the growth and supply of medical-grade cannabis throughout Israel. The firm also dedicates resources to establishing new cultivation infrastructure.
- CEO
- Ajay Singh Kaila
- IPO
- 2017
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $1.76K
- P/E
- -0.47
- P/S
- 0.00
- P/B
- 7.55
- EV/EBITDA
- -0.97
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -221.78%
- ROIC
- -0.05%
- Revenue
- $0 · 0.00%
- Net Income
- $-4,693,070 · 81.34%
- EPS
- $-0.03 · 82.33%
- Op Income
- $-2,392,224
- FCF YoY
- 58.65%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.19
- Avg Volume
- 46.75K
Get TickerSpark's AI analysis on ISCNF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ISCNF coverage
Recent articles, reports, and earnings notes.
No research on ISCNF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ISCNF report →Similar companies
Peers in the same neighborhood.